Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates

March 17, 2026 3:53 PM

Stifel analyst Stephen Willey lowered the price target on Abeona Therapeutics (NASDAQ: ABEO) to $17.00 (from $19.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found